Aging does not impact drug--drug interaction magnitudes with antiretrovirals
The risk of drug–drug interactions (DDIs) is elevated in aging people living with HIV (PLWH) because of highly prevalent age-related comorbidities leading to more comedications. To investigate the impact of aging on DDI magnitudes between comedications (amlodipine, atorvastatin, rosuvastatin) and boosted darunavir, we conducted a clinical trial in aging PLWH aged at least 55 years. DDI magnitudes were comparable with those reported in young individuals supporting that the clinical management of DDIs in aging PLWH can be similar.
Source: AIDS - Category: Infectious Diseases Tags: Research Letters Source Type: research
More News: Atorvastatin Calcium | Clinical Trials | Crestor | HIV AIDS | Infectious Diseases | Lipitor | Norvasc | Prezista | Rosuvastatin | Statin Therapy | Zivast